Pharmacy Benefit Managers:

Early Results on Ventures With Drug Manufacturers

T-HEHS-96-85: Published: Feb 7, 1996. Publicly Released: Feb 7, 1996.

Additional Materials:


Office of Public Affairs
(202) 512-4800

GAO discussed the role of pharmacy benefit managers (PBM) in the health care market, focusing on the effects of mergers between pharmaceutical manufacturers and PBM. GAO found that: (1) PBM help health insurers control their drug costs by encouraging the use of formularies, creating pharmacy networks, negotiating rebates with drug manufacturers, substituting generic drugs, and conducting drug utilization reviews; (2) drug manufacturers merge with PBM to increase their profits and market share and develop disease management programs; (3) critics believe that continued mergers between drug manufacturers and PBM will reduce market competition and hinder new PBM from entering the drug market; (4) the Federal Trade Commission (FTC) has taken action against some PBM-manufacturer mergers and developed safeguards to ensure that drug formularies and their cost designations and market competition remain fair; and (5) determining whether PBM adhere to pro-competition safeguards will be difficult, since it will require access to PBM proprietary information.

Apr 26, 2017

Apr 17, 2017

Apr 14, 2017

Apr 10, 2017

Mar 31, 2017

Mar 2, 2017

Feb 27, 2017

Feb 15, 2017

Feb 13, 2017

Feb 8, 2017

Looking for more? Browse all our products here